Best therapeutic approach in metastatic hormone-sensitive prostate cancer based on disease volume: a systematic review and network meta-analysis

The results provide collective evidence for treatment selection based on disease volume and timing of metastasis with strongest survival benefits of triplets for high-volume/synchronous mHSPC patients and of ARPI doublets for low-volume disease.

Authors

Institutions

Publication Details

Journal
The Oncologist
Published
2025-11-15
DOI
https://doi.org/10.1093/oncolo/oyaf386
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Best therapeutic approach in metastatic hormone-sensitive prostate cancer based on disease volume: a systematic review and network meta-analysis

Massimo Di Maïo, Fabrizio Di Costanzo, Pasquale Rescigno, Giovanni Dima et al.
The Oncologist
Prostate Cancer Treatment and Research
article

Best therapeutic approach in metastatic hormone-sensitive prostate cancer based on disease volume: a systematic review and network meta-analysis

Massimo Di Maïo, Fabrizio Di Costanzo, Pasquale Rescigno, Giovanni Dima, Matteo Santoni, Christoph Oing, Alessio Signori, Luca Galli, Alberto Briganti, Vincenza Conteduca, Luigi Formisano, Sara Elena Rebuzzi, Carlo G. M. Messina, Giuseppe Procopio, Francesco Montorsi, Brigida Anna Maiorano, Giuseppe Fornarini, Andrea Necchi, Chiara Mercinelli, Giuseppe Luigi Banna, Ugo De Giorgi
article en

Abstract

The results provide collective evidence for treatment selection based on disease volume and timing of metastasis with strongest survival benefits of triplets for high-volume/synchronous mHSPC patients and of ARPI doublets for low-volume disease.

The OncologistVol. 31(2)
University of Foggia (IT), University of Salento (IT), Vita-Salute San Raffaele University (IT), Newcastle upon Tyne Hospitals NHS Foundation Trust (GB), Ospedale San Paolo (IT), Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT), Ospedale Santa Chiara (IT), Portsmouth Hospitals NHS Trust (GB), Ospedale San Paolo (IT), Ospedali Riuniti di Foggia (IT), Mylan (South Africa) (ZA), Department of Medical Sciences (BY), IRCCS Ospedale San Raffaele (IT), University of Palermo (AR), Tumori Foundation (US), Ospedale Policlinico San Martino (IT), Ospedale Vito Fazzi (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT), Ospedale di Macerata, University of Macerata (IT), University of Turin (IT), University of Portsmouth (GB), University of Naples Federico II (IT), University of Genoa (IT), Newcastle University (GB)
Openalex Percentile: Top 50%
Prostate Cancer Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.